AM NURSERY GROUP LIMITED
Opportunity 70/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (77/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-05-31 | 2024-05-31 |
|---|
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
Recent activity
- • 1 accounts
- • 1 accounts
Corporate timeline (6 events)Click to expand
- 2026-02-27📄accounts-with-accounts-type-dormantaccounts · AA
- 2025-02-20📄accounts-with-accounts-type-dormantaccounts · AA
- 2023-05-09🏢Company incorporatedAs AM NURSERY GROUP LIMITED
- 2023-05-09➕MOUGHAL, Mohammed Aurqeeb appointedsecretary
- 2023-05-09➕MOUGHAL, Mohammed Aurqeeb appointeddirector
- 2023-05-09📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Young company: Only 3.0 years old — management layer unlikely to be developed.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Mohammed Aurqeeb Moughal Individual · British · DOB 01/1976 · age 50 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 09/05/2023 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · G postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| AMIRS HEALTHCARE LIMITED→ SC633331 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AR DENTAL LIMITED→ SC400032 · est 2011 · no financials extracted | — | — | — | — | 14y | — | — |
| ARCHEGOS MEDICAL IMAGING LIMITED→ SC812129 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ARDPEATON LIMITED→ SC780810 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ARICOM SATELLITE LIMITED→ SC678887 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| ARRAN PHARMACY LIMITED→ SC222920 · est 2001 · no financials extracted | — | — | — | — | 24y | — | — |
| ASHPHARM GLASGOW LTD→ SC628555 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| ASPECT AUTISM CONSULTANCY LTD→ SC806061 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| AT HOME HEARING SOLUTIONS LTD→ SC588857 · est 2018 · no financials extracted | — | — | — | — | 8y | — | — |
| ATPL CONSULTING LTD→ SC594562 · est 2018 · no financials extracted | — | — | — | — | 8y | — | — |
| AUCHENTORLIE LTD→ SC857287 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AUCHINAIRN FOREST KINDERGARTEN LTD→ SC857221 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 0 resigned)
Click a director name to see their full track record across all companies.